BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10705875)

  • 1. Lack of association between hyperprolactinemia and colon carcinoma.
    Carlson HE; Zarrabi MH; Lyubsky SL
    Cancer Invest; 2000; 18(2):130-4. PubMed ID: 10705875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and tissue prolactin detection in colon carcinoma.
    Indinnimeo M; Cicchini C; Memeo L; Stazi A; Ghini C; Ricci F; Reale MG; Mingazzini P
    Oncol Rep; 2001; 8(6):1351-3. PubMed ID: 11605064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia and immunohistochemical expression of intracellular prolactin and prolactin receptor in primary central nervous system tumors and their relationship with cellular replication.
    Soares Leães CG; Filho AP; Pereira Lima JF; Dallago CM; Batista RL; Barbosa-Coutinho LM; Ferreira NP; da Costa Oliveira M
    Brain Tumor Pathol; 2007; 24(2):41-6. PubMed ID: 18095129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of prolactin secretion.
    Benker G; Jaspers C; Häusler G; Reinwein D
    Klin Wochenschr; 1990 Dec; 68(23):1157-67. PubMed ID: 2126309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
    Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
    Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolactinemia is a frequent finding in HIV infection but does not correlate with viral burden].
    Montero A; Giovannoni AG; Sen L
    Medicina (B Aires); 2000; 60(4):427-30. PubMed ID: 11188945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
    Lissoni P; Messina G; Rovelli F; Brivio F; Fumagalli L; Villa S; Bartolacelli E
    In Vivo; 2009; 23(6):987-9. PubMed ID: 20023245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of calcium infusion on serum prolactin in hyperprolactinemic women.
    Yildiz L; Uyanik BS; Kuşkay S; Küçük M
    J Basic Clin Physiol Pharmacol; 1995; 6(3-4):303-7. PubMed ID: 8852276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
    Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and colorectal cancer: is there a connection?
    Baert D; Matthys C; Gillardin JP; Lepoutre L; Thienpont L; Kaufman JM; Cuvelier C; De Vos M
    Acta Gastroenterol Belg; 1998; 61(4):407-9. PubMed ID: 9923090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic production of prolactin in uterine cervical carcinoma.
    Hsu CT; Yu MH; Lee CY; Jong HL; Yeh MY
    Gynecol Oncol; 1992 Feb; 44(2):166-71. PubMed ID: 1544594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
    Hattori N; Inagaki C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis.
    Notsu K; Ito Y; Furuya H; Ohguni S; Kato Y
    Endocr J; 1997 Feb; 44(1):89-94. PubMed ID: 9152619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.